
INTRODUCTION
It is now clear that IBD is increasing worldwide and has become a global emergent disease. IBD, which includes Crohn’s disease (CD) and ulcerative colitis (UC), has been considered a real problem in all societies.
The 2nd Crohn's & Colitis Conference Bahrain (CCCB 2025), which is scheduled to take place at the Sheraton hotel in the Kingdom of Bahrain on April 25–26, 2025, is organized by Al Kindi Hospital in collaboration with the event organizer, Mobility Health Consultants. The CCCB 2025 will highlight remarkable advancements in the clinical care of ulcerative colitis and Crohn's disease, as well as practical guidance and novel knowledge.
The conference will create an ideal opportunity for gastroenterologists, surgeons, internists, clinicians, pharmacists, nurses, and other health professionals to be brought up to date on inflammatory bowel diseases, and, in particular, Crohn's disease and ulcerative colitis, and provides a state-of-the-art platform for the exchange of scientific advances in the prevention, diagnosis, and management of inflammatory bowel diseases.
The CCCB 2025 is an exciting educational activity led by recognized experts in the field of IBD that cannot be missed. The scientific program provides a multidisciplinary approach to the assessment, diagnosis, and treatment strategies of IBD management presented by top-notch international, regional, and local experts who will show the most recent data and give their valuable opinion on how to improve local practice. The interactive and discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops.
WHO SHOULD ATTEND?
- The 2nd Crohn's & Colitis Conference Bahrain (CCCB 2025) attracts a large range of delegates
- surgeons
- family physicians
- radiologists
- pharmacists
- healthcare planners
- including gastroenterologists
- internists
- general practitioners
- microbiologists
- nurses
- and other healthcare professionals seeking updated information on inflammatory bowel disease management.